Cargando…
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
BACKGROUND: A multitude of recent studies has observed common epigenetic changes develop in tumour cells of multiple lineages following exposure to stresses such as hypoxia, chemotherapeutics, immunotherapy or targeted therapies. A significant increase in the transcriptionally repressive mark trimet...
Autores principales: | Torrano, Joachim, Al Emran, Abdullah, Hammerlindl, Heinz, Schaider, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408861/ https://www.ncbi.nlm.nih.gov/pubmed/30850015 http://dx.doi.org/10.1186/s13148-019-0644-y |
Ejemplares similares
-
H3K9me3-binding proteins are dispensable for SETDB1/H3K9me3-dependent retroviral silencing
por: Maksakova, Irina A, et al.
Publicado: (2011) -
Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance
por: Hammerlindl, Heinz, et al.
Publicado: (2017) -
Setdb1 is required for germline development and silencing of H3K9me3-marked endogenous retroviruses in primordial germ cells
por: Liu, Sheng, et al.
Publicado: (2014) -
The H3K9 methyltransferase SETDB1 maintains female identity in Drosophila germ cells
por: Smolko, Anne E., et al.
Publicado: (2018) -
H3K14ac is linked to methylation of H3K9 by the triple Tudor domain of SETDB1
por: Jurkowska, Renata Z., et al.
Publicado: (2017)